XML 70 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Financial Data (Unaudited)
 12 Months Ended
Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Data (Unaudited)
Quarterly Financial Data (Unaudited)

 
First
Quarter (a)
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter (b)
2013
 
 
 
 
 
 
 
Revenue from services
$
110,315,840

 
$
110,768,343

 
$
108,047,986

 
$
109,178,547

Gross profit
$
28,875,395

 
$
27,838,891

 
$
28,184,087

 
$
28,561,465

 
 
 
 
 
 
 
 
(Loss) income from continuing operations, net of tax
$
(1,345,729
)
 
$
(1,435,829
)
 
$
1,453,590

 
$
(52,922,043
)
Income (loss) from discontinued operations, net of tax
$
2,503,763

 
$
(21,393
)
 
$
(538,916
)
 
$
337,234

Net income (loss)
$
1,158,034

 
$
(1,457,222
)
 
$
914,674

 
$
(52,584,809
)
 
 
 
 
 
 
 
 
Basic income (loss) per common share from:
 

 
 

 
 

 
 

Continuing operations
$
(0.04
)
 
$
(0.05
)
 
$
0.05

 
$
(1.70
)
Discontinuing operations
0.08

 
—

 
(0.02
)
 
0.01

Net income (loss)
$
0.04

 
$
(0.05
)
 
$
0.03

 
$
(1.69
)
 
 
 
 
 
 
 
 
Diluted income (loss) per common share from:
 

 
 

 
 

 
 

Continuing operations
$
(0.04
)
 
$
(0.05
)
 
$
0.05

 
$
(1.70
)
Discontinuing operations
0.08

 
—

 
(0.02
)
 
0.01

Net income (loss)
$
0.04

 
$
(0.05
)
 
$
0.03

 
$
(1.69
)
 
 
First
Quarter
 
Second
Quarter (c)
 
Third
Quarter (c)
 
Fourth
Quarter (c)
2012
 
 
 
 
 
 
 
Revenue from services
$
109,799,496

 
$
108,847,135

 
$
112,257,707

 
$
111,730,808

Gross profit
$
29,049,682

 
$
27,136,129

 
$
27,455,827

 
$
27,943,467

 
 
 
 
 
 
 
 
Income (loss) from continuing operations, net of tax
$
361,955

 
$
(18,841,283
)
 
$
719,539

 
$
(2,985,180
)
(Loss) income from discontinued operations, net of tax
$
(946,322
)
 
$
4,337,450

 
$
(18,319,626
)
 
$
(6,548,030
)
Net loss
$
(584,367
)
 
$
(14,503,833
)
 
$
(17,600,087
)
 
$
(9,533,210
)
 
 
 
 
 
 
 
 
Basic (loss) income per common share from:
 

 
 

 
 

 
 

Continuing operations
$
0.01

 
$
(0.61
)
 
$
0.02

 
$
(0.10
)
Discontinuing operations
(0.03
)
 
0.14

 
(0.59
)
 
(0.21
)
Net loss
$
(0.02
)
 
$
(0.47
)
 
$
(0.57
)
 
$
(0.31
)
 
 
 
 
 
 
 
 
Diluted (loss) income per common share from:
 

 
 

 
 

 
 

Continuing operations
$
0.01

 
$
(0.61
)
 
$
0.02

 
$
(0.10
)
Discontinuing operations
(0.03
)
 
0.14

 
(0.59
)
 
(0.21
)
Net loss
$
(0.02
)
 
$
(0.47
)
 
$
(0.57
)
 
$
(0.31
)
________________
(a)
The Company sold its clinical trial services business on February 15, 2013. The clinical trial services business has been classified as discontinued operations. The transaction resulted in a gain on sale of $3,968,714 pretax, or $2,055,907 after tax. See Note 3 – Assets Held for Sale and Discontinued Operations.
(b)
On December 2, 2013, the Company acquired the operating assets of On Assignment, Inc.’s Allied Healthcare Staffing division. The acquisition has been accounted for in accordance with FASB ASC Topic 805-Business Combinations, using the purchase method. The results of On Assignment's operations have been included in the Company's consolidated statements of operations since December 2, 2013, the date of the acquisition. See Note 5 - Acquisitions. During the fourth quarter of 2013, the Company recorded a deferred tax assets valuation allowance of approximately $48,406,398 and a trade names impairment charge of $6,400,000. See Note 12 - Income Taxes and Note 4 - Goodwill, Trade Names and Other Identifiable Intangible Assets.
(c)
During the second, third and fourth quarters of 2012, the Company recorded impairment charges of approximately $18,732,000, $23,500,000 and $11,900,000, respectively. See Note 4 – Goodwill, Trade Names and Other Identifiable Intangible Assets and Note 3 – Assets Held for Sale and Discontinued Operations.